Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence.

Luca Gregorio GiaccariMaria Caterina PacePassavanti Maria BeatriceFrancesca GarganoCaterina AurilioPasquale Sansone

Published in: Life (Basel, Switzerland) (2021)

C/T may be a valid therapeutic option to treat multidrug-resistant (MDR), extensively drug-resistant (XDR), pandrug-resistant (PDR), and carbapenem-resistant (CR) PA infections. However, further data are necessary to define the optimal treatment dosage and duration.

Keyphrases

multidrug resistant
drug resistant
gram negative
acinetobacter baumannii
pseudomonas aeruginosa
klebsiella pneumoniae
cystic fibrosis
electronic health record
big data
machine learning
replacement therapy
deep learning
artificial intelligence